A detailed history of Baird Financial Group, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 24,142 shares of OGN stock, worth $355,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,142
Previous 27,220 11.31%
Holding current value
$355,611
Previous $563,000 18.12%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $57,404 - $70,886
-3,078 Reduced 11.31%
24,142 $461,000
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $12,895 - $16,228
739 Added 2.79%
27,220 $563,000
Q1 2024

May 14, 2024

BUY
$13.78 - $18.8 $12,870 - $17,559
934 Added 3.66%
26,481 $497,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $3.53 Million - $5.59 Million
-322,792 Reduced 92.67%
25,547 $368,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $5 Million - $7.16 Million
301,245 Added 639.67%
348,339 $6.05 Million
Q2 2023

Aug 11, 2023

SELL
$19.27 - $24.63 $6.78 Million - $8.67 Million
-351,982 Reduced 88.2%
47,094 $980,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $704,975 - $1.06 Million
-32,912 Reduced 7.62%
399,076 $9.39 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $5,779 - $8,459
247 Added 0.45%
55,001 $1.29 Million
Q2 2022

Aug 08, 2022

SELL
$31.66 - $38.9 $7,123 - $8,752
-225 Reduced 0.41%
54,754 $1.85 Million
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $1.05 Million - $1.35 Million
-34,363 Reduced 38.46%
54,979 $1.92 Million
Q4 2021

Feb 09, 2022

BUY
$28.67 - $37.13 $355,421 - $460,300
12,397 Added 16.11%
89,342 $2.72 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $189,816 - $236,293
-6,630 Reduced 7.93%
76,945 $2.52 Million
Q2 2021

Aug 11, 2021

BUY
$28.45 - $38.0 $2.38 Million - $3.18 Million
83,575 New
83,575 $2.53 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.